Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Radiation sensitization with redox modulators: a promising approach.

Abby Rosenberg1, Susan Knox

  • 1Department of Radiation Oncology, Stanford University Medical Center, Stanford, CA 94305-5152, USA.

International Journal of Radiation Oncology, Biology, Physics
|January 18, 2006
PubMed
Summary

New redox modulators aim to improve radiation therapy efficacy by targeting tumor cells. These agents, including hypoxic cell sensitizers and oxygen delivery enhancers, show promise in preclinical and clinical studies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Qualitative Study of CMC Caregivers' Perspectives about their Emotional Well-Being.

Journal of pain and symptom management·2025
Same author

Who Better Than Palliative Care? Supporting Clinicians in the Face of Serious Illness.

Journal of pain and symptom management·2024
Same author

Experiences in Coping with Stress-A Qualitative Study of Family Caregivers of Children with Medical Complexity.

Children (Basel, Switzerland)·2024
Same author

Ethics of Patient-Clinician Boundaries in Oncology: Communication Strategies for Promoting Clinician Well-Being and Quality Patient Care.

JCO oncology practice·2024
Same author

RADx-UP Coordination and Data Collection: An Infrastructure for COVID-19 Testing Disparities Research.

American journal of public health·2022
Same author

Basics of Physics and Radiobiology for Radiopharmaceutical Therapies.

Practical radiation oncology·2022

Area of Science:

  • Oncology
  • Radiotherapy
  • Pharmacology

Background:

  • Radiation therapy is crucial for cancer control but faces limitations like toxicity and tumor hypoxia.
  • Enhancing radiation therapy efficacy is a key goal in cancer treatment.
  • Biologic agents modulating reduction/oxidation reactions are being explored to overcome these limitations.

Purpose of the Study:

  • To review five promising redox modulators currently in development for enhancing radiation therapy.
  • To summarize available safety and efficacy data for these agents.
  • To highlight the current investigative landscape and future directions in radiosensitizer development.

Main Methods:

  • Review of published preclinical and clinical data, including abstracts and posters.

Related Experiment Videos

  • Focus on five specific redox modulators: Tirapazamine, AQ4N, RSR13, Motexafin gadolinium, and HIF-1 inhibitors.
  • Analysis of mechanisms including hypoxic cell sensitization, oxygen delivery, targeted DNA damage, and transcription factor inhibition.

    • Main Results:

    • Tirapazamine and AQ4N act as hypoxic cell sensitizers.
    • RSR13 improves oxygen delivery to tumor cells.
    • Motexafin gadolinium selectively targets tumor cells to enhance DNA damage.
    • HIF-1 inhibitors target key regulators of hypoxia response.

    Conclusions:

    • There is a significant need for safer agents to augment radiation therapy efficacy.
    • The reviewed redox modulators represent promising strategies in radiosensitizer development.
    • These agents have the potential to increase tumor cell radiosensitivity without harming normal tissues.